— Know what they know.
Not Investment Advice

OMID OTC

OMID Holdings, Inc.
1W: -3.8% 1M: -20.6% 3M: -64.5% YTD: -39.7% 1Y: -6.0% 3Y: -81.5% 5Y: -78.2%
$0.02
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 38 · $1.7M mcap · Short 83% of daily vol

Income Trends

Revenue
$394K +59.2% ▲
5Y CAGR: -21.6%
Gross Profit
-$66K +75.9% ▲
Operating Income
-$316K +46.0% ▲
Net Income
-$178K +79.1% ▲
EPS (Diluted)
$-0.00 +79.5% ▲
EBITDA
-$299K +37.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$2M$2M$522K$248K$394K
YoY Growth+61.6%-27.8%-66.3%-52.6%+59.2%
Cost of Revenue$1M$2M$462K$523K$460K
Gross Profit$854K-$88K$60K-$275K-$66K
Gross Margin39.7%-5.7%11.5%-111.2%-16.8%
R&D Expenses$0$0$0$0$0
SG&A Expenses$336K$392K$347K$310K$250K
Operating Expenses$336K$392K$347K$310K$250K
Operating Income$518K-$479K-$286K-$585K-$316K
Operating Margin24.1%-30.9%-54.8%-236.2%-80.2%
Interest Expense$0$0$0$233K$0
Income Before Tax$539K-$469K$35K-$732K-$176K
Tax Expense$55K-$139K$713$118K$2K
Net Income$484K-$331K$35K-$851K-$178K
Net Margin22.5%-21.3%6.6%-343.5%-45.1%
EPS (Diluted)$0.00$-0.00$0.00$-0.01$-0.00
EBITDA$560K-$445K$57K-$476K-$299K
Shares Outstanding175M96M96M96M96M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms